Samantha Burnham
Samantha Burnham
Senior Director Clinical Development, Eli Lilly
Verified email at
Cited by
Cited by
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of Neurology 69 (10), 1318-1325, 2012
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
VL Villemagne, V Doré, SC Burnham, CL Masters, CC Rowe
Nature Reviews Neurology 14 (4), 225-236, 2018
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ...
Molecular psychiatry 18 (8), 875-881, 2013
Blood-based molecular biomarkers for Alzheimer’s disease
H Zetterberg, SC Burnham
Molecular brain 12 (1), 26, 2019
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a …
SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ...
The Lancet Neurology 15 (10), 1044-1053, 2016
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
RF Buckley, EC Mormino, RE Amariglio, MJ Properzi, JS Rabin, YY Lim, ...
Alzheimer's & Dementia 14 (9), 1193-1203, 2018
Intense physical activity is associated with cognitive performance in the elderly
BM Brown, JJ Peiffer, HR Sohrabi, A Mondal, VB Gupta, SR Rainey-Smith, ...
Translational psychiatry 2 (11), e191-e191, 2012
Aβ-amyloid and tau imaging in dementia
VL Villemagne, V Dore, P Bourgeat, SC Burnham, S Laws, O Salvado, ...
Seminars in nuclear medicine 47 (1), 75-88, 2017
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ...
Molecular psychiatry 19 (4), 519-526, 2014
Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies
RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ...
Journal of Alzheimer's Disease 62 (3), 965-992, 2018
Association of β-amyloid and apolipoprotein E ε4 with memory decline in preclinical Alzheimer disease
YY Lim, P Kalinowski, RH Pietrzak, SM Laws, SC Burnham, D Ames, ...
JAMA neurology 75 (4), 488-494, 2018
Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial
MJ Pontecorvo, M Lu, SC Burnham, AE Schade, JL Dage, S Shcherbinin, ...
JAMA neurology 79 (12), 1250-1259, 2022
Influence of BDNF Val66Met on the relationship between physical activity and brain volume
BM Brown, P Bourgeat, JJ Peiffer, S Burnham, SM Laws, ...
Neurology 83 (15), 1345-1352, 2014
Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults
SM Laws, S Gaskin, A Woodfield, V Srikanth, D Bruce, PE Fraser, T Porter, ...
Scientific reports 7 (1), 9766, 2017
Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study: progress and observations from 2,359 older adults spanning the spectrum from cognitive normality …
C Fowler, SR Rainey-Smith, S Bird, J Bomke, P Bourgeat, BM Brown, ...
Journal of Alzheimer's disease reports 5 (1), 443-468, 2021
The feasibility of at-home iPad cognitive testing for use in clinical trials
DM Rentz, M Dekhtyar, J Sherman, S Burnham, D Blacker, SL Aghjayan, ...
The journal of prevention of Alzheimer's disease 3 (1), 8, 2016
Structural core of the executive control network: A high angular resolution diffusion MRI study
K Shen, T Welton, M Lyon, AN McCorkindale, GT Sutherland, S Burnham, ...
Human brain mapping 41 (5), 1226-1236, 2020
Computerized cognitive testing for use in clinical trials: a comparison of the NIH Toolbox and Cogstate C3 batteries
RF Buckley, KP Sparks, KV Papp, M Dekhtyar, C Martin, S Burnham, ...
The journal of prevention of Alzheimer's disease 4 (1), 3, 2017
Australian Imaging B, Lifestyle Research G (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
Lancet Neurol 12 (4), 357-367, 0
The system can't perform the operation now. Try again later.
Articles 1–20